RELEVANCE: Phase III randomized study of lenalidomide plus rituximab (R2) versus chemotherapy plus rituximab, followed by rituximab maintenance, in patients with previously untreated follicular lymphoma.

Author:

Fowler Nathan Hale1,Morschhauser Franck2,Feugier Pierre3,Bouabdallah Reda4,Tilly Herve5,Palomba Maria Lia6,Fruchart Christophe7,Libby Edward N.8,Casasnovas Olivier9,Gomes Da Silva Maria10,Pranger Delphine11,Zachee Pierre12,Martin Garcia-Sancho Alejandro13,Lopez-Guillermo Armando14,Larouche Jean-Francois15,Ando Kiyoshi16,Liu Dongfang17,Wang Jianming17,Xerri Luc4,Salles Gilles A.18

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX;

2. Centre Hospitalier Universitaire Régional de Lille, Unité GRITA, Lille, France;

3. CHU Brabois Service d'Hématologie et Médecine Interne, Vandoeuvre Les Nancy, France;

4. Institut Paoli-Calmettes, Marseille, France;

5. Centre Henri Becquerel, University of Rouen, Rouen, France;

6. Memorial Sloan Kettering Cancer Center, New York, NY;

7. Institut d'Hématologie de Basse Normandie, Caen, France;

8. University of Washington, Seattle, WA;

9. CHU Le Bocage Service d'Hématologie Clinique, Dijon, France;

10. Instituto Português de Lisboa Francisco Gentil, IPOLFG-EPE Departamento Hematologia, Lisboa, Portugal;

11. Grand Hôpital de Charleroi, Charleroi, Belgium;

12. ZNA Stuivenberg, Antwerp, Belgium;

13. Hospital Universitario de Salamanca and IBSAL, CIBERONC, Salamanca, Spain;

14. Hospital Clínic de Barcelona, Barcelona, Spain;

15. CHU de Quebec Hopital de l'Enfant-Jesus, Quebec, QC, Canada;

16. Tokai University Hospital, Kanagawa, Japan;

17. Celgene Corporation, Summit, NJ;

18. Hospices Civils de Lyon, Université Lyon-1, Lyon, France;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3